Heart Failure
RSSArticles
-
Should the Cath Lab Be Activated?
How should one interpret the ECG in the figure? Should the cardiac cath lab be activated on the basis of this ECG?
-
Heart Health and Cognitive Decline: Who Fares Better?
More middle-age men might be living with various cardiovascular risk factors and diseases, but the associated negative effects on cognition could be worse for women of the same age with the same conditions.
-
Jugular Venous Pressure by Bedside Ultrasound
Using a handheld point-of-care ultrasound device to estimate right atrial pressure from images of the jugular vein resulted in a higher imaging success rate vs. visual inspection and a reasonably accurate estimation, especially in those with elevated right atrial pressures.
-
Beyond COVID, Other Key Research Breakthroughs Occurred in 2021
American Heart Association highlights progress on diabetes treatment, stroke prevention, and anti-clotting medication.
-
Role of Beta-Blockers in Heart Failure with Preserved Ejection Fraction
Discontinuation of beta-blockers in heart failure with preserved ejection fraction patients significantly improved quality of life scores and expanded exercise capacity.
-
Slow, Steady, and Synchronized Wins the Race
In patients with atrial fibrillation and heart failure, definitive rate control via atrioventricular junction ablation and biventricular pacing resulted in a significant reduction in all-cause mortality vs. pharmacologic rate control.
-
USPSTF Recommends Against Using Aspirin as a Heart Attack Prevention Tool
Instead of protecting against various cardiovascular ailments, the drug might cause more harm than good in otherwise healthy older patients.
-
Benefits of Early Coronary Angiography in Acute Heart Failure
For patients hospitalized with acute heart failure, invasive coronary angiography within 14 days was associated with higher rates of coronary revascularization and lower rates of all-cause death, cardiovascular mortality, and heart failure hospitalization.
-
Iron Therapy for Acute Heart Failure
Giving intravenous ferric carboxymaltose to stabilized post-acute heart failure patients with iron deficiency improved quality of life vs. placebo-treated patients within four weeks, which persisted during subsequent therapy for up to 24 weeks.
-
Slow, Steady, and Synchronized Wins the Race
In patients with atrial fibrillation and heart failure, definitive rate control via atrioventricular junction ablation and biventricular pacing resulted in a significant reduction in all-cause mortality vs. pharmacologic rate control.